R&D

Introduction

한미약품은 연구 개발에 대한 끊임없는 열정으로 글로벌 신약 개발을 위해 노력하고 있습니다.

Armed with a passion for R&D, Hanmi continues its drive to develop innovative drugs.

‘Respect for Human Life’ and ‘Value Creation’ are two core values that are important to Hanmi, and we uphold them via our scientific research and achievements. Hanmi continues to show the highest R&D investment-to-revenue among listed healthcare companies in Korea.

2016 Sales 883 Bil Won2016 R&D investment 163 Bil Won Ratio of R&D investment 18.4%Ratio of R&D investment 18.4%